GSK-3 as a novel prognostic indicator in leukemia

Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues

Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629 · see citing works

The ground state of embryonic stem cell self-renewal

Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442 · see citing works

β‐catenin is a target for the ubiquitin–proteasome pathway

Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,533 · see citing works

Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization

Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · see citing works

Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

Sato, N., Meijer, L., Skaltsounis, A., Greengard, P., & Brivanlou, A. H. (2003) · Nature Medicine · doi:10.1038/nm979 · Cited by 2,107 · see citing works

Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition

Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581 · see citing works

Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly

Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C. J., Munemitsu, S. M., & Polakis, P. G. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,420 · see citing works

Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia

Raaijmakers, M. H. G. P., Mukherjee, S., Guo, S., Zhang, S., Kobayashi, T., Schoonmaker, J. A., Ebert, B. L., Al-Shahrour, F., Hasserjian, R. P., Scadden, E. O., et al. (2010) · Nature · doi:10.1038/nature08851 · Cited by 1,115 · see citing works

Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1

Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881 · see citing works

SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction

Inuzuka, H., Shaik, S., Onoyama, I., Gao, D., Tseng, A., Maser, R. S., Zhai, B., Wan, L., Gutiérrez, A., Lau, A. W., et al. (2011) · Nature · doi:10.1038/nature09732 · Cited by 635 · see citing works

Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells

Bellodi, C., Lidonnici, M. R., Hamilton, A., Helgason, G. V., Soliera, A. R., Ronchetti, M., Galavotti, S., Young, K. W., Selmi, T., Yacobi, R., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35660 · Cited by 570 · see citing works

Integrating Patterning Signals: Wnt/GSK3 Regulates the Duration of the BMP/Smad1 Signal

Fuentealba, L. C., Eivers, E., Ikeda, A., Hurtado, C., Kuroda, H., Pera, E. M., & Robertis, E. M. D. (2007) · Cell · doi:10.1016/j.cell.2007.09.027 · Cited by 555 · see citing works

Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts

Kode, A., Manavalan, J. S., Mosialou, I., Bhagat, G., Rathinam, C. V., Luo, N., Khiabanian, H., Lee, A., Murty, V. V. V. S., Friedman, R. A., et al. (2014) · Nature · doi:10.1038/nature12883 · Cited by 530 · see citing works

GSK-3 as potential target for therapeutic intervention in cancer

McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Sokolosky, M. L., Abrams, S. L., Montalto, G., D’Assoro, A. B., Libra, M., Nicoletti, F., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2037 · Cited by 511 · see citing works

Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistance

Carew, J. S., Nawrocki, S. T., Kahue, C. N., Zhang, H., Yang, C., Chung, L., Houghton, J. A., Huang, P., Giles, F. J., & Cleveland, J. L. (2007) · Blood · doi:10.1182/blood-2006-10-050260 · Cited by 487 · see citing works

Wnt-dependent Regulation of the E-cadherin Repressor Snail

Yook, J. I., Li, X., Ota, I., Fearon, E. R., & Weiss, S. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413878200 · Cited by 443 · see citing works

Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemiaPreprint

Glaser, S. P., Lee, E. F., Trounson, E., Bouillet, P., Wei, A. H., Fairlie, W. D., Izon, D. J., Zuber, J. A., Rappaport, A., Herold, M. J., et al. (2012) · Genes & Development · doi:10.1101/gad.182980.111 · Cited by 427 · see citing works

The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase

Wei, W., Jin, J., Schlisio, S., Harper, J. W., & Kaelin, W. G. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.005 · Cited by 403 · see citing works

Drugging RAS: know the enemy

Papke, B., & Der, C. J. (2017) · Science · doi:10.1126/science.aam7622 · Cited by 399 · see citing works

Glycogen synthase kinase-3: functions in oncogenesis and development

Plyte, S. E. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(92)90012-n · Cited by 377 · see citing works

Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse

Kaufmann, S. H., Karp, J. E., Svingen, P. A., Krajewski, S., Burke, P. J., Gore, S. D., & Reed, J. C. (1998) · Blood · doi:10.1182/blood.v91.3.991.991_991_1000 · Cited by 368 · see citing works

The Protooncogene TCL1 Is an Akt Kinase Coactivator

Laine, J. T., Künstle, G., Obata, T., Ma, S., & Noguchi, M. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00039-3 · Cited by 327 · see citing works

Origin and Differentiation of Human and Murine Stroma

Dennis, J. E., & Charbord, P. (2002) · Stem Cells · doi:10.1634/stemcells.20-3-205 · Cited by 312 · see citing works

Opposing effects of Tcf3 and Tcf1 control Wnt stimulation of embryonic stem cell self-renewal

Yi, F., Pereira, L., Hoffman, J. A., Shy, B. R., Yuen, C. M., Liu, D. R., & Merrill, B. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2283 · Cited by 303 · see citing works

Regulation of GSK-3

Harwood, A. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00412-3 · Cited by 291 · see citing works

Judging a Protein by More Than Its Name: GSK-3

Woodgett, J. R. (2001) · Science s STKE · doi:10.1126/stke.2001.100.re12 · Cited by 279 · see citing works

AKT in cancer: new molecular insights and advances in drug development

Mundi, P. S., Sachdev, J., McCourt, C., & Kalinsky, K. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13021 · Cited by 272 · see citing works

Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia

Kornblau, S. M., Womble, M., Qiu, Y. H., Jackson, C. E., Chen, W., Konopleva, M. Y., Estey, E. H., & Andreeff, M. (2006) · Blood · doi:10.1182/blood-2006-02-003475 · Cited by 266 · see citing works

Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy

Wang, Z., Smith, K. S., Murphy, M., Piloto, O., Somervaille, T. C. P., & Cleary, M. L. (2008) · Nature · doi:10.1038/nature07284 · Cited by 265 · see citing works

β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells.

Yeung, J., Esposito, M., Gandillet, A., Zeisig, B., Griessinger, E., Bonnet, D., & So, C. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.032 · Cited by 264 · see citing works

Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation

Abrahamsson, A., Geron, I., Gotlib, J., Dao, K.-H. T., Barroga, C., Newton, I., Giles, F., Durocher, J., Creusot, R. S., Karimi, M., et al. (2009) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0900189106 · Cited by 264 · see citing works

Emerging roles for RGS proteins in cell signalling

Hepler, J. R. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01369-3 · Cited by 258 · see citing works

Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention

McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Abrams, S. L., Montalto, G., D’Assoro, A. B., Libra, M., Nicoletti, F., Maestro, R., et al. (2013) · Leukemia · doi:10.1038/leu.2013.184 · Cited by 255 · see citing works

Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention

Davis, N. M., Sokolosky, M. L., Stadelman, K. M., Abrams, S. L., Libra, M., Candido, S., Nicoletti, F., Polesel, J., Maestro, R., D’Assoro, A. B., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2209 · Cited by 252 · see citing works

FLT3 Mutations: Biology and Treatment

SMALL, D. M. (2006) · Hematology · doi:10.1182/asheducation-2006.1.178 · Cited by 246 · see citing works

Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression

Ghosh, A. K., Secreto, C. R., Knox, T. R., Ding, W., Mukhopadhyay, D., & Kay, N. E. (2009) · Blood · doi:10.1182/blood-2009-09-242719 · Cited by 227 · see citing works

Glycogen Synthase Kinase 3

Patel, P., & Woodgett, J. R. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.11.011 · Cited by 211 · see citing works

<i>GSK3B</i> polymorphisms alter transcription and splicing in Parkinson's disease

Kwok, J. B. J., Hallupp, M., Loy, C. T., Chan, D. K. Y., Woo, J., Mellick, G. D., Buchanan, D. D., Silburn, P. A., Halliday, G. M., & Schofield, P. R. (2005) · Annals of Neurology · doi:10.1002/ana.20691 · Cited by 205 · see citing works

Regulation of protein stability by GSK3 mediated phosphorylation

Xu, C. B., Kim, N., & Gumbiner, B. M. (2009) · Cell Cycle · doi:10.4161/cc.8.24.10111 · Cited by 205 · see citing works

Role of FLT3 in leukemia

Gilliland, D. G., & Griffin, J. D. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200207000-00003 · Cited by 201 · see citing works

ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia

Jiang, Q., Crews, L. A., Barrett, C. L., Chun, H.-J. E., Court, A. C., Isquith, J. M., Zipeto, M., Goff, D. J., Minden, M. D., Sadarangani, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213021110 · Cited by 188 · see citing works

Signaling specificity in the Akt pathway in biology and disease

Toker, A., & Marmiroli, S. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.04.001 · Cited by 188 · see citing works

Hematopoietic Stem Cell Niche in Health and Disease

Hoggatt, J., Kfoury, Y. S., & Scadden, D. T. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044414 · Cited by 169 · see citing works

Secondary mutations as mediators of resistance to targeted therapy in leukemia

Daver, N. G., Cortes, J. E., Ravandi, F., Patel, K. P., Burger, J. A., Konopleva, M. Y., & Kantarjian, H. M. (2015) · Blood · doi:10.1182/blood-2014-10-605808 · Cited by 161 · see citing works

Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia

SHAO, S., Su, L., Qin, Y., Wang, X., Yang, Y., Bai, H., Zhou, L., Zhao, C., & Wang, C. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2313 · Cited by 154 · see citing works

Dual Inhibition of Bcl-2 and Bcl-xL Strikingly Enhances PI3K Inhibition-Induced Apoptosis in Human Myeloid Leukemia Cells through a GSK3- and Bim-Dependent Mechanism

Rahmani, M., Aust, M. M., Attkisson, E., Williams, D. C., Ferreira‐Gonzalez, A., & Grant, S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1365 · Cited by 153 · see citing works

Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer

McCubrey, J. A., Rakus, D., Gizak, A., Steelman, L. S., Abrams, S. L., Lertpiriyapong, K., Fitzgerald, T. L., Yang, L. V., Montalto, G., Cervello, M., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.09.004 · Cited by 149 · see citing works

Regulation of Nanog Expression by Phosphoinositide 3-Kinase-dependent Signaling in Murine Embryonic Stem Cells

Storm, M. P., Bone, H. K., Beck, C. G., Bourillot, P.-Y., Schreiber, V., Damiano, T., Nelson, A. S., Savatier, P., & Welham, M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610906200 · Cited by 147 · see citing works

Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells

Fitzgerald, T. L., Lertpiriyapong, K., Cocco, L., Martelli, A. M., Libra, M., Candido, S., Montalto, G., Cervello, M., Steelman, L. S., Abrams, S. L., et al. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.06.003 · Cited by 144 · see citing works

The broken “Off” switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance

Ruvolo, P. P. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.08.002 · Cited by 143 · see citing works

Inhibition of Mcl-1 with the pan–Bcl-2 family inhibitor (–)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia

Pan, R. A., Ruvolo, V. R., Wei, J., Konopleva, M. Y., Reed, J. C., Pellecchia, M., Andreeff, M., & Ruvolo, P. P. (2015) · Blood · doi:10.1182/blood-2014-10-604975 · Cited by 140 · see citing works

A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia

de Toni, F., Racaud‐Sultan, C., Chicanne, G., Mas, V. M., Cariven, C., Briand‐Mésange, F., Salles, J., Demur, C., Allouche, M., Payrastre, B., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209346 · Cited by 132 · see citing works

PLC and PI3K/Akt/mTOR signalling in disease and cancer

Follo, M. Y., Manzoli, L., Poli, A., McCubrey, J. A., & Cocco, L. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.10.004 · Cited by 127 · see citing works

The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications

Medyouf, H. (2017) · Blood · doi:10.1182/blood-2016-11-696070 · Cited by 127 · see citing works

GSK-3 Promotes Conditional Association of CREB and Its Coactivators with MEIS1 to Facilitate HOX-Mediated Transcription and Oncogenesis

Wang, Z., 岩崎, 正., Ficara, F., Lin, C., Matheny, C., Wong, S. H. K., Smith, K. S., & Cleary, M. L. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.024 · Cited by 124 · see citing works

The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCδ and proteasome-dependent regulation of Mcl-1 expression

Baudot, A. D., Jeandel, P. Y., Mouska, X., Maurer, U., Tartare‐Deckert, S., Raynaud, S., Cassuto, J. P., Ticchioni, M., & Deckert, M. (2009) · Oncogene · doi:10.1038/onc.2009.179 · Cited by 121 · see citing works

Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis

McCubrey, J. A., Abrams, S. L., Fitzgerald, T. L., Cocco, L., Martelli, A. M., Montalto, G., Cervello, M., Scalisi, A., Candido, S., Libra, M., et al. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.09.016 · Cited by 116 · see citing works

Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells

McCubrey, J. A., Fitzgerald, T. L., Yang, L. V., Lertpiriyapong, K., Steelman, L. S., Abrams, S. L., Montalto, G., Cervello, M., Neri, L. M., Cocco, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13991 · Cited by 112 · see citing works

The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia

Banerji, V., Frumm, S. M., Ross, K. N., Li, L. S., Schinzel, A. C., Hahn, C. K., Kakoza, R. M., Chow, K. T., Ross, L., Alexe, G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci46465 · Cited by 105 · see citing works

Unraveling MCL-1 degradation

Opferman, J. T. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401978 · Cited by 100 · see citing works

Role of Microenvironment in Resistance to Therapy in AML

Tabe, Y., & Konopleva, M. Y. (2015) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-015-0253-6 · Cited by 98 · see citing works

Wnt Signaling Behaves as a “Master Regulator” in the Osteogenic and Adipogenic Commitment of Human Amniotic Fluid Mesenchymal Stem Cells

D’Alimonte, I., Lannutti, A., Pipino, C., Tomo, P. D., Pierdomenico, L., Cianci, E., Antonucci, I., Marchisio, M., Romano, M., Stuppia, L., et al. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9436-5 · Cited by 98 · see citing works

Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?

Patel, S., & Woodgett, J. R. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.013 · Cited by 98 · see citing works

Glucocorticoids Inhibit Cell Cycle Progression in Differentiating Osteoblasts via Glycogen Synthase Kinase-3β

Smith, E., Coetzee, G. A., & Frenkel, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109708200 · Cited by 92 · see citing works

Apoptosis and autophagy have opposite roles on imatinib-induced K562 leukemia cell senescence

Drullion, C., Trégoat, C., Lagarde, V, Tan, S., Gioia, R., Priault, M., Djavaheri-Mergny, M., Brisson, A., Auberger, P., Mahon, F.-X., et al. (2012) · Cell Death &amp; Disease · doi:10.1038/cddis.2012.111 · Cited by 88 · see citing works

PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting

Ciuffreda, L., Falcone, I., Incani, U. C., Curatolo, A. D., Conciatori, F., Matteoni, S., Vari, S., Vaccaro, V., Cognetti, F., & Milella, M. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.07.002 · Cited by 83 · see citing works

Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia

Konopleva, M. Y., Walter, R. B., Faderl, S. H., Jabbour, E. J., Zeng, Z., Borthakur, G. M., Huang, X., Kadia, T. M., Ruvolo, P. P., Feliu, J. B., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1978 · Cited by 83 · see citing works

An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia

Rizzieri, D. A., Cooley, S., Odenike, O. M., Moonan, L., Chow, K. H., Jackson, K. A., Wang, X., Brail, L. H., & Borthakur, G. M. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1122781 · Cited by 83 · see citing works

Implication of PI3K/Akt pathway in pancreatic cancer: When PI3K isoforms matter?

Baer, R., Cintas, C., Therville, N., & Guillermet‐Guibert, J. (2015) · Advances in Biological Regulation · doi:10.1016/j.jbior.2015.05.001 · Cited by 81 · see citing works

Phosphatase and tensin homologue phosphorylation in the C‐terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome

Cheong, J., Eom, J.-I., Maeng, H. M., Lee, S., Hahn, J. S., Ko, Y. W., & Min, Y. H. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04452.x · Cited by 81 · see citing works

Myb proteins: angels and demons in normal and transformed cells

Zhou, Y. E. (2010) · Frontiers in bioscience · doi:10.2741/3738 · Cited by 80 · see citing works

Mcl-1 Ubiquitination and Destruction

Inuzuka, H., Fukushima, H., Shaik, S., Liu, P., Lau, A. W., & Wei, W. (2011) · Oncotarget · doi:10.18632/oncotarget.242 · Cited by 79 · see citing works

Wnt1 and MEK1 Cooperate to Promote Cyclin D1 Accumulation and Cellular Transformation

Rimerman, R. A., Gellert-Randleman, A., & Diehl, J. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910241199 · Cited by 78 · see citing works

GSK-3β promotes cell survival by modulating Bif-1-dependent autophagy and cell death

Yang, J., Takahashi, Y., Cheng, E., Liu, J., Terranova, P. F., Zhao, B., Thrasher, J. B., Wang, H., & Li, B. (2010) · Journal of Cell Science · doi:10.1242/jcs.060475 · Cited by 74 · see citing works

Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: A tale of two complexes

Jhanwar‐Uniyal, M., Gillick, J. L., Neil, J. A., Tobias, M. E., Thwing, Z. E., & Murali, R. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.09.004 · Cited by 74 · see citing works

RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation

Schwäble, J., Choudhary, C., Thiede, C., Tickenbrock, L., Sargin, B., Steur, C., Rehage, M., Rudat, A., Brandts, C., Berdel, W. E., et al. (2004) · Blood · doi:10.1182/blood-2004-03-0940 · Cited by 74 · see citing works

Mcl-1 as a therapeutic target in acute myelogenous leukemia (AML)

Bose, P., & Grant, S. (2013) · Leukemia Research Reports · doi:10.1016/j.lrr.2012.11.006 · Cited by 72 · see citing works

Distinct Functions of Sox2 Control Self-Renewal and Differentiation in the Osteoblast Lineage

Seo, E., Basu-Roy, U., Zavadil, J., Basilico, C., & Mansukhani, A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05798-11 · Cited by 72 · see citing works

RNA rewriting, recoding, and rewiring in human disease

Zipeto, M., Jiang, Q., Melese, E. S., & Jamieson, C. H. M. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.07.001 · Cited by 70 · see citing works

Protein Kinase C Regulates Human Pluripotent Stem Cell Self-Renewal

Kinehara, M., Kawamura, S., Tateyama, D., Suga, M., Matsumura, H., Mimura, S., Hirayama, N., Hirata, M., Uchio‐Yamada, K., Kohara, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054122 · Cited by 69 · see citing works

Achieving specificity in Akt signaling in cancer

Toker, A. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.09.020 · Cited by 68 · see citing works

GSK3 Deficiencies in Hematopoietic Stem Cells Initiate Pre-neoplastic State that Is Predictive of Clinical Outcomes of Human Acute Leukemia

Guezguez, B., Almakadi, M., Benoit, Y. D., Shapovalova, Z., Rahmig, S., Fiebig‐Comyn, A., Casado, F. L., Tanasijevic, B., Bresolin, S., Masetti, R., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.11.012 · Cited by 64 · see citing works

Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium

Lin, K., Huang, M., & Liu, H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.025 · Cited by 62 · see citing works

Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNK

Dai, Y., Rahmani, M., Pei, X., Khanna, P., Han, S. I., Mitchell, C., Dent, P., & Grant, S. (2004) · Blood · doi:10.1182/blood-2004-07-2767 · Cited by 61 · see citing works

Cross-talk between the CK2 and AKT signaling pathways in cancer

Ruzzene, M., Bertacchini, J., Toker, A., & Marmiroli, S. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.03.002 · Cited by 61 · see citing works

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?

Pleyer, L., Valent, P., & Greil, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071009 · Cited by 60 · see citing works

Glycogen Synthase Kinase-3β Mediates Endoplasmic Reticulum Stress-Induced Lysosomal Apoptosis in Leukemia

Huang, W., Lin, Y.-S., Chen, C., Wang, C., Chiu, W. C., & Lin, C. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.148122 · Cited by 56 · see citing works

GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb

Zhou, F., Zhang, L., van Laar, T., van Dam, H., & ten Dijke, P. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-06-0483 · Cited by 55 · see citing works

Growth Factor Withdrawal and Apoptosis: The Middle Game

Letai, A. G. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.005 · Cited by 54 · see citing works

PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL

El‐Gamal, D., Williams, K., LaFollette, T. D., Cannon, M. J., Blachly, J. S., Zhong, Y., Woyach, J. A., Williams, E., Awan, F. T., Jones, J. J., et al. (2014) · Blood · doi:10.1182/blood-2014-05-574830 · Cited by 53 · see citing works

Targeting the transcription factor Myb by small-molecule inhibitors

Uttarkar, S., Frampton, J., & Klempnauer, K. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.12.003 · Cited by 52 · see citing works

GSK3 is a regulator of RAR-mediated differentiation

Gupta, K., Gulen, F., Sun, L., Aguilera, R., Chakrabarti, A., Kiselar, J., Agarwal, M. K., & Wald, D. N. (2012) · Leukemia · doi:10.1038/leu.2012.2 · Cited by 50 · see citing works

A New α5β1 Integrin-Dependent Survival Pathway Through GSK3β Activation in Leukemic Cells

de Toni, F., Despeaux, M., Bertrand, J., Bourogâa, E., Ysebaert, L., Payrastre, B., & Racaud‐Sultan, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009807 · Cited by 49 · see citing works

Integrin alphavbeta3 enhances β-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity

Yi, H., Zeng, D., Shen, Z., Liao, J., Wang, X., Liu, Y. Z., Zhang, X., & Kong, P. (2016) · Oncotarget · doi:10.18632/oncotarget.9617 · Cited by 48 · see citing works

Judging a Protein by More Than Its Name: GSK-3

Woodgett, J. R. (2001) · Science Signaling · doi:10.1126/scisignal.1002001re12 · Cited by 46 · see citing works

The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells

Brenner, A. K., Tvedt, T. H. A., & Bruserud, Ø. (2016) · Molecules · doi:10.3390/molecules21111512 · Cited by 44 · see citing works

Regulators of G protein signaling: role in hematopoiesis, megakaryopoiesis and platelet function

Louwette, S., Geet, C. V., & Freson, K. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04903.x · Cited by 43 · see citing works

FLT3 Tyrosine Kinase Inhibition as a Paradigm for Targeted Drug Development in Acute Myeloid Leukemia

Grunwald, M. R., & Levis, M. J. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.03.004 · Cited by 42 · see citing works

Transcription regulation and chromatin structure in the pluripotent ground state

Marks, H., & Stunnenberg, H. G. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.09.005 · Cited by 42 · see citing works

Glycogen synthase kinase−3β inhibitors suppress leukemia cell growth

Song, E. Y., Palladinetti, P., Klamer, G., Ko, K., Lindeman, R., O'Brien, T. A., & Dolnikov, A. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.06.001 · Cited by 40 · see citing works

Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients

Ruvolo, P. P., Qiu, Y., Coombes, K. R., Zhang, N., Neeley, E. S., Ruvolo, V. R., Hail, N., Borthakur, G. M., Konopleva, M. Y., Andreeff, M., et al. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.07.001 · Cited by 39 · see citing works

Molecular Pathways: Epigenetic Modulation of Wnt–Glycogen Synthase Kinase-3 Signaling to Target Human Cancer Stem Cells

Benoit, Y. D., Guezguez, B., Boyd, A. L., & Bhatia, M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2491 · Cited by 38 · see citing works

Crosstalk between tyrosine kinase receptors, GSK3 and BMP2 signaling during osteoblastic differentiation of human mesenchymal stem cells

Biver, E., Thouverey, C., Magne, D., & Caverzasio, J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.09.018 · Cited by 37 · see citing works

A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity

Hu, S., Ueda, M., Stetson, L. C., Ignatz-Hoover, J. J., Moreton, S. A., Chakrabarti, A., Xia, Z., Karan, G., Lima, M. J. G. D., Agrawal, M., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0566 · Cited by 37 · see citing works

PTEN and leukemia stem cells

Fragoso, R., & Barata, J. T. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2014.05.005 · Cited by 36 · see citing works

E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation

Lochab, S., Pal, P., Kapoor, I., Kanaujiya, J. K., Sanyal, S., Behre, G., & Trivedi, A. K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.018 · Cited by 35 · see citing works

Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells

Liu, H., Hu, X., Zhu, Y., Jiang, G., & Chen, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-4510-z · Cited by 32 · see citing works

β-Catenin in Pluripotency

Sineva, G. S., & Pospelov, V. A. (2014) · International review of cytology · doi:10.1016/b978-0-12-800178-3.00002-6 · Cited by 32 · see citing works

PKR activity is required for acute leukemic cell maintenance and growth: A role for PKR‐mediated phosphatase activity to regulate GSK‐3 phosphorylation

Blalock, W. L., Grimaldi, C., Falà, F., Follo, M., Horn, S., Bäsecke, J., Martinelli, G., Cocco, L., & Martelli, A. M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21848 · Cited by 31 · see citing works

Proapoptotic Activity and Chemosensitizing Effect of the Novel Akt Inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-Cell Acute Lymphoblastic Leukemia

Falà, F., Blalock, W. L., Tazzari, P. L., Cappellini, A., Chiarini, F., Martinelli, G., Tafuri, A., McCubrey, J. A., Cocco, L., & Martelli, A. M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047639 · Cited by 31 · see citing works

The Multitargeted Receptor Tyrosine Kinase Inhibitor Linifanib (ABT-869) Induces Apoptosis through an Akt and Glycogen Synthase Kinase 3β–Dependent Pathway

Hernandez‐Davies, J. E., Zape, J. P., Landaw, E. M., Tan, X., Presnell, A., Griffith, D., Heinrich, M. C., Glaser, K. B., & Sakamoto, K. M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0904 · Cited by 30 · see citing works

The Role of Glycogen Synthase Kinase-3β in Normal Haematopoiesis, Angiogenesis and Leukaemia

Holmes, T., O'Brien, T. A., Knight, R., Lindeman, R., Symonds, G. P., & Dolnikov, A. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708784638834 · Cited by 29 · see citing works

Dual inhibition of AKT/FLT3-ITD by A674563 overcomes FLT3 ligand-induced drug resistance in FLT3-ITD positive AML

Wang, A., Wu, H., Cheng, C., Hu, C., Qi, Z., Wang, W., Yu, K., Liu, X., Zou, F., Zhao, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8675 · Cited by 27 · see citing works

EGF Inhibits Wnt/β‐Catenin‐Induced Osteoblast Differentiation by Promoting β‐Catenin Degradation

Boonanantanasarn, K., Lee, H., Baek, K., Woo, K. M., Ryoo, H., Baek, J., & Kim, G. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25231 · Cited by 22 · see citing works

Studying The Right Cell In Acute Myelogenous Leukemia: Dynamic Changes Of Apoptosis And Signal Transduction Pathway Protein Expression In Chemotherapy Resistant Ex-Vivo Selected “Survivor Cells”

Kornblau, S. M., Qiu, Y. H., Bekele, B. N., Cade, J. S., Zhou, X., Harris, D., Jackson, E., Estrov, Z. E., & Andreeff, M. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3507 · Cited by 17 · see citing works

The novel arylindolylmaleimide PDA-66 displays pronounced antiproliferative effects in acute lymphoblastic leukemia cells

Kretzschmar, C., Roolf, C., Langhammer, T.-S., Sekora, A., Pews‐Davtyan, A., Beller, M., Frech, M. J., Eisenlöffel, C., Rolfs, A., & Junghanß, C. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-71 · Cited by 15 · see citing works

Phosphorylation of Serine422 increases the stability and transactivation activities of human Osterix

Xu, Y., Yao, B., Shi, K., Lü, J., Jin, Y., Qi, B., Li, H., Pan, S., Chen, L., & Ma, C. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.02.021 · Cited by 12 · see citing works

GSK3 and its interactions with the PI3K/AKT/mTOR signalling network

Hermida, M. A., Kumar, J. D., & Leslie, N. R. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.06.003 · Cited by 482 · see citing works

Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implications

Liu, T., Lv, Y., Zhao, J., You, Q., & Jiang, Z. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.034 · Cited by 172 · see citing works

Role of protein phosphatases in the cancer microenvironment

Ruvolo, P. P. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.07.006 · Cited by 59 · see citing works

Galectins as regulators of cell survival in the leukemia niche

Ruvolo, P. P. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.09.003 · Cited by 49 · see citing works

Mesenchymal Stem Cells Promote Caspase Expression in Molt-4 Leukemia Cells Via GSK-3α/Β and ERK1/2 Signaling Pathways as a Therapeutic Strategy

Fathi, E., & Vietor, I. (2020) · Current Gene Therapy · doi:10.2174/1566523220666201005111126 · Cited by 48 · see citing works

Metformin influences drug sensitivity in pancreatic cancer cells

Candido, S., Abrams, S. L., Steelman, L. S., Lertpiriyapong, K., Martelli, A. M., Cocco, L., Ratti, S., Follo, M. Y., Murata, R. M., Rosalen, P. L., et al. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.02.002 · Cited by 48 · see citing works

The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response

Martelli, A. M., Paganelli, F., Fazio, A., Bazzichetto, C., Conciatori, F., & McCubrey, J. A. (2019) · Cancers · doi:10.3390/cancers11050629 · Cited by 46 · see citing works

Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells

Abrams, S. L., Follo, M. Y., Steelman, L. S., Lertpiriyapong, K., Cocco, L., Ratti, S., Martelli, A. M., Candido, S., Libra, M., Murata, R. M., et al. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.10.003 · Cited by 45 · see citing works

Targeting the phosphatidylinositol 3‐kinase/Akt/mechanistic target of rapamycin signaling pathway in B‐lineage acute lymphoblastic leukemia: An update

Simioni, C., Martelli, A. M., Zauli, G., Vitale, M., McCubrey, J. A., Capitani, S., & Neri, L. M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26539 · Cited by 42 · see citing works

Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia

Ricciardi, M. R., Mirabilii, S., Licchetta, R., Piedimonte, M., & Tafuri, A. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.05.002 · Cited by 40 · see citing works

Targeting Akt/PKB in pediatric tumors: A review from preclinical to clinical trials

Toson, B., Fortes, I. S., Roesler, R., & de Andrade, S. F. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106403 · Cited by 39 · see citing works

Fructose-1,6-bisphosphatase: From a glucose metabolism enzyme to multifaceted regulator of a cell fate

Gizak, A., Duda, P., Wiśniewski, J., & Rakus, D. (2019) · Advances in Biological Regulation · doi:10.1016/j.jbior.2019.03.001 · Cited by 37 · see citing works

Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals

Abrams, S. L., Lertpiriyapong, K., Yang, L. V., Martelli, A. M., Cocco, L., Ratti, S., Falasca, M., Murata, R. M., Rosalen, P. L., Lombardi, P., et al. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.06.002 · Cited by 36 · see citing works

Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1α pathway

Yoshikawa, Y., Takano, O., Kato, I., Takahashi, Y., Shima, F., & Kataoka, T. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.017 · Cited by 33 · see citing works

AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill FLT3-ITD acute myeloid leukemia

Post, S. M., Ma, H., Malaney, P., Zhang, X., Aitken, M. J. L., Mak, P. Y., Ruvolo, V. R., Yasuhiro, T., Kozaki, R., Chan, L. E., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.278369 · Cited by 33 · see citing works

Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells—Power of nutraceuticals

McCubrey, J. A., Abrams, S. L., Lertpiriyapong, K., Cocco, L., Ratti, S., Martelli, A. M., Candido, S., Libra, M., Murata, R. M., Rosalen, P. L., et al. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.09.012 · Cited by 32 · see citing works

FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1

Mishra, M., Thacker, G., Sharma, A., Singh, A. K., Upadhyay, V., Sanyal, S., Verma, S. P., Tripathi, A. K., Bhatt, M. L. B., & Trivedi, A. K. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0268 · Cited by 30 · see citing works

Antitumor effect of baicalin from the Scutellaria baicalensis radix extract in B-acute lymphoblastic leukemia with different chromosomal rearrangements

Orzechowska, B., Wróbel, G., Turlej, E., Jatczak, B., Sochocka, M., & Chaber, R. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106114 · Cited by 30 · see citing works

Roles of galectin‑3 in the tumor microenvironment and tumor metabolism (Review)

Guo, Y., Shen, R., Yu, L., Zheng, X., Cui, R., Song, Y., & Wang, D. (2020) · Oncology Reports · doi:10.3892/or.2020.7777 · Cited by 31 · see citing works

Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia

Gowda, C. S., Soliman, M., Kapadia, M. A., Ding, Y., Payne, K. J., & Dovat, S. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.06.001 · Cited by 27 · see citing works

Dual inhibition of PI3K/mTOR signaling in chemoresistant AML primary cells

Bertacchini, J., Frasson, C., Chiarini, F., D'Avella, D., Accordi, B., Anselmi, L., Barozzi, P., Forghieri, F., Luppi, M., Martelli, A. M., et al. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.03.001 · Cited by 22 · see citing works

Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines

Chappell, W. H., Candido, S., Abrams, S. L., Russo, S. M., Ove, R., Martelli, A. M., Cocco, L., Ramazzotti, G., Cervello, M., Montalto, G., et al. (2018) · Advances in Biological Regulation · doi:10.1016/j.jbior.2018.05.002 · Cited by 22 · see citing works

The GSK3β/Mcl-1 axis is regulated by both FLT3-ITD and Axl and determines the apoptosis induction abilities of FLT3-ITD inhibitors

Qiu, Y., Li, Y., Chai, M., Hua, H., Wang, R., Waxman, S., & Jing, Y. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01317-0 · Cited by 19 · see citing works

HDAC and Ku70 axis- an effective target for apoptosis induction by a new 2-cyano-3-oxo-1,9-dien glycyrrhetinic acid analogue

Gong, P., Li, K., Li, Y., Liu, D., Zhao, L., & Jing, Y. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0602-1 · Cited by 19 · see citing works

GSK-3 and miRs: Master regulators of therapeutic sensitivity of cancer cells

Duda, P., Akula, S. M., Abrams, S. L., Steelman, L. S., Gizak, A., Rakus, D., & McCubrey, J. A. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118770 · Cited by 16 · see citing works

CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease

Yan, S., Liu, H., Liu, Z.-Y., Peng, F.-P., Jiang, F.-J., Li, L., & Fu, R. (2019) · Cancer Medicine · doi:10.1002/cam4.2608 · Cited by 13 · see citing works

Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation

Lee, J. K., Chatterjee, A., Scarpa, M., Bailey, C. M., Niyongere, S., Singh, P., Ali, M. K. M., Kapoor, S., Wang, Y., Silvestri, G., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0379 · Cited by 12 · see citing works

Glycogen Synthase Kinase-3 and phospholipase C-beta signalling: Roles and possible interactions in myelodysplastic syndromes and acute myeloid leukemia

Ratti, S., Mongiorgi, S., Rusciano, I., Manzoli, L., & Follo, M. Y. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118649 · Cited by 11 · see citing works

GSK-3 signaling in health

McCubrey, J. A., & Cocco, L. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.06.004 · Cited by 10 · see citing works

Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Facilitates Cell Proliferation in Human Cholesteatoma Keratinocytes

Zhang, C., Liu, Y.-W., Chi, Z., & Chen, B. (2020) · PPAR Research · doi:10.1155/2020/8864813 · Cited by 6 · see citing works

Landscape of FLT3 Variations Associated with Structural and Functional Impact on Acute Myeloid Leukemia: A Computational Study

Mirza, Z., Al-Saedi, D. A., Alganmi, N. A., & Karim, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063419 · Cited by 7 · see citing works

SAR Probing of KX2-391 Provided Analogues With Juxtaposed Activity Profile Against Major Oncogenic Kinases

Omar, A. M., Khayat, M. T. A., Ahmed, F., Muhammad, Y. A., Malebari, A. M., Ibrahim, S. M., Khan, M. I., Shah, D. K., Childers, W. E., & El‐Araby, M. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.879457 · Cited by 4 · see citing works

Targeting Wnt Signaling in Acute Lymphoblastic Leukemia

Hurwitz, S., Lee, K. J., Fourfouris, T., Choi, I. F., Parikh, K., Friedmann, R., Zarrabi, M., & Kim, Y. (2025) · Cancers · doi:10.3390/cancers17152456 · Cited by 3 · see citing works

Galectins-1, -3 and -9 in leukemia: mechanistic insights and therapeutic translation

Wang, T., Zhang, Y., Guo, Y., Zhao, M., Cai, X., & Feng, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1685266 · Cited by 3 · see citing works

Overcoming the sorafenib resistance mechanism in FLT3-mutated acute myeloid leukemia: molecular basis and new targets

Peng, H., Li, M., Peng, Y. Y., Li, X. L., Yang, J., Sun, Q. G., & Song, K. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1713174 · Cited by 1 · see citing works

Development and validation of an LC–MS/MS method for quantitative determination of GS87, a novel antineoplastic agent, in mouse plasma

Kunati, S. R., Yang, S., Wald, D. N., & Xu, Y. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.02.034 · Cited by 1 · see citing works

Data from Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation

Lee, J. K., Chatterjee, A., Scarpa, M., Bailey, C. M., Niyongere, S., Singh, P., Ali, M. K. M., Kapoor, S., Wang, Y., Silvestri, G., et al. (2024) · doi:10.1158/2767-9764.c.7078148.v1

GSK3β high /NFATc1 high subtype targeting overcomes therapy resistance in pancreatic cancer through transcriptional induction of homologous recombination repair

Latif, M. U., Liu, X., Bockelmann, A., Huhnold, L., Schmídt, G., Klein, L., Zhao, X., Conradi, L., Conrads, K., Weber, A. L., et al. (2025) · Gut · doi:10.1136/gutjnl-2025-336227

GSK-3: a multifaceted player in acute leukemias

Martelli, A. M., Evangelisti, C., Paganelli, F., Chiarini, F., & McCubrey, J. A. (2021) · Leukemia · doi:10.1038/s41375-021-01243-z · Cited by 34 · see citing works

OPEN REVIEW

(2016)

Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention

McCubrey, J. A., Steelman, L. S., Bertrand, F. E., Davis, N. M., Abrams, S. L., Montalto, G., D’Assoro, A. B., Libra, M., Nicoletti, F., Maestro, R., et al. (2013) · Leukemia · doi:10.1038/leu.2013.184 · Cited by 255 · see citing works

Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy

Wang, Z., Smith, K. S., Murphy, M., Piloto, O., Somervaille, T. C. P., & Cleary, M. L. (2008) · Nature · doi:10.1038/nature07284 · Cited by 265 · see citing works

Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies

Martelli, A. M., Paganelli, F., Evangelisti, C., Chiarini, F., & McCubrey, J. A. (2022) · Cells · doi:10.3390/cells11111812 · Cited by 16 · see citing works